{
  "DOI": "10.1038/s41431-022-01148-0",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01148-0",
  "alternative-id": [
    "1148"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "23 June 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "28 June 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "3 October 2022"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "I have received honoraria from AstraZenca and MSD (Merck and Co.), the manufacturers of the PARP-inhibitor olaparib."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-1003-1997",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Benusiglio",
      "given": "Patrick R.",
      "sequence": "first"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        10,
        11
      ]
    ],
    "date-time": "2022-10-11T14:02:54Z",
    "timestamp": 1665496974000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        10,
        11
      ]
    ],
    "date-time": "2022-10-11T14:04:54Z",
    "timestamp": 1665497094000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        10,
        11
      ]
    ],
    "date-time": "2022-10-11T14:41:49Z",
    "timestamp": 1665499309872
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2022,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            10,
            1
          ]
        ],
        "date-time": "2022-10-01T00:00:00Z",
        "timestamp": 1664582400000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            10,
            1
          ]
        ],
        "date-time": "2022-10-01T00:00:00Z",
        "timestamp": 1664582400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01148-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01148-0",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01148-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1097-1099",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        10,
        3
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/s41431-020-0692-y",
      "author": "N Flaum",
      "doi-asserted-by": "publisher",
      "first-page": "1541",
      "journal-title": "Eur J Hum Genet",
      "key": "1148_CR1",
      "unstructured": "Flaum N, Morgan RD, Burghel GJ, Bulman M, Clamp AR, Hasan J, et al. Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England. Eur J Hum Genet. 2020;28:1541–7.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1038/srep29506",
      "author": "A George",
      "doi-asserted-by": "publisher",
      "journal-title": "Sci Rep.",
      "key": "1148_CR2",
      "unstructured": "George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, et al. Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep. 2016;6:29506.",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2019.4428",
      "author": "Z Kemp",
      "doi-asserted-by": "publisher",
      "first-page": "e194428",
      "journal-title": "JAMA Netw Open",
      "key": "1148_CR3",
      "unstructured": "Kemp Z, Turnbull A, Yost S, Seal S, Mahamdallie S, Poyastro-Pearson E, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open. 2019;2:e194428.",
      "volume": "2",
      "year": "2019"
    },
    {
      "DOI": "10.1056/NEJMoa1706450",
      "author": "M Robson",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "journal-title": "N Engl J Med",
      "key": "1148_CR4",
      "unstructured": "Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377:523–33.",
      "volume": "377",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMoa2105215",
      "author": "ANJ Tutt",
      "doi-asserted-by": "publisher",
      "first-page": "2394",
      "journal-title": "N Engl J Med",
      "key": "1148_CR5",
      "unstructured": "Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, et al. Adjuvant Olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med. 2021;384:2394–405.",
      "volume": "384",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMoa1903387",
      "author": "T Golan",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "journal-title": "N Engl J Med",
      "key": "1148_CR6",
      "unstructured": "Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, et al. Maintenance Olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med. 2019;381:317–27.",
      "volume": "381",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41431-020-00778-6",
      "author": "C Lefol",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "journal-title": "Eur J Hum Genet",
      "key": "1148_CR7",
      "unstructured": "Lefol C, Sohier E, Baudet C, Naïbo P, Ruano E, Grand-Masson C, et al. Acquired somatic MMR deficiency is a major cause of MSI tumor in patients suspected for “Lynch-like syndrome” including young patients. Eur J Hum Genet. 2021;29:482–8.",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.1200/PO.20.00525",
      "author": "R Pearlman",
      "doi-asserted-by": "publisher",
      "first-page": "779",
      "journal-title": "JCO Precis Oncol",
      "key": "1148_CR8",
      "unstructured": "Pearlman R, Frankel WL, Swanson BJ, Jones D, Zhao W, Yilmaz A, et al. Prospective statewide study of universal screening for hereditary colorectal cancer: the Ohio colorectal cancer prevention initiative. JCO Precis Oncol. 2021;5:779–91.",
      "volume": "5",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41431-017-0010-5",
      "author": "A Kievit",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "journal-title": "Eur J Hum Genet févr",
      "key": "1148_CR9",
      "unstructured": "Kievit A, Tessadori F, Douben H, Jordens I, Maurice M, Hoogeboom J, et al. Variants in members of the cadherin–catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome. Eur J Hum Genet févr. 2018;26:210–9.",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S1470-2045(20)30219-9",
      "author": "VR Blair",
      "doi-asserted-by": "publisher",
      "first-page": "e386",
      "journal-title": "Lancet Oncol",
      "key": "1148_CR10",
      "unstructured": "Blair VR, McLeod M, Carneiro F, Coit DG, D’Addario JL, Dieren JMvan, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21:e386–97.",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1038/gim.2017.11",
      "author": "J Ghoumid",
      "doi-asserted-by": "publisher",
      "first-page": "1013",
      "journal-title": "Genet Med",
      "key": "1148_CR11",
      "unstructured": "Ghoumid J, Stichelbout M, Jourdain AS, Frenois F, Lejeune-Dumoulin S, Alex-Cordier MP, et al. Blepharocheilodontic syndrome is a CDH1 pathway–related disorder due to mutations in CDH1 and CTNND1. Genet Med. 2017;19:1013–21.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ejhg.2017.134",
      "author": "O Calvete",
      "doi-asserted-by": "publisher",
      "first-page": "1278",
      "journal-title": "Eur J Hum Genet",
      "key": "1148_CR12",
      "unstructured": "Calvete O, Garcia-Pavia P, Domínguez F, Bougeard G, Kunze K, Braeuninger A, et al. The wide spectrum of POT1 gene variants correlates with multiple cancer types. Eur J Hum Genet. 2017;25:1278–81.",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ncomms9383",
      "author": "O Calvete",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Commun",
      "key": "1148_CR13",
      "unstructured": "Calvete O, Martinez P, Garcia-Pavia P, Benitez-Buelga C, Paumard-Hernández B, Fernandez V, et al. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families. Nat Commun. 2015;6:8383.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1053/j.semdp.2007.10.006",
      "author": "A Burke",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "journal-title": "Semin Diagn Pathol",
      "key": "1148_CR14",
      "unstructured": "Burke A. Primary malignant cardiac tumors. Semin Diagn Pathol. 2008;25:39–46.",
      "volume": "25",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ng.2941",
      "author": "J Shi",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "journal-title": "Nat Genet",
      "key": "1148_CR15",
      "unstructured": "Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet. 2014;46:482–6.",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jnci/dju384",
      "author": "MN Bainbridge",
      "doi-asserted-by": "publisher",
      "first-page": "dju384",
      "journal-title": "JNCI J Natl Cancer Inst",
      "key": "1148_CR16",
      "unstructured": "Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H, et al. Germline mutations in shelterin complex genes are associated with familial glioma. JNCI J Natl Cancer Inst. 2015;107:dju384.",
      "volume": "107",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41375-021-01335-w",
      "author": "TL Lim",
      "doi-asserted-by": "publisher",
      "first-page": "283",
      "journal-title": "Leukemia",
      "key": "1148_CR17",
      "unstructured": "Lim TL, Lieberman DB, Davis AR, Loren AW, Hausler R, Bigdeli A, et al. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms. Leukemia. 2022;36:283–7.",
      "volume": "36",
      "year": "2022"
    }
  ],
  "reference-count": 17,
  "references-count": 17,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01148-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The European Journal of Human Genetics is turning 30: a selection of major cancer genetics papers published by the Journal"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}